DocGo Inc. (NASDAQ:DCGO) Shares Sold by Aigen Investment Management LP

Aigen Investment Management LP cut its stake in DocGo Inc. (NASDAQ:DCGO) by 41.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,951 shares of the company’s stock after selling 12,651 shares during the period. Aigen Investment Management LP’s holdings in DocGo were worth $60,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. nVerses Capital LLC lifted its stake in DocGo by 151.5% during the 2nd quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock valued at $26,000 after acquiring an additional 5,000 shares during the period. Gladius Capital Management LP acquired a new stake in DocGo during the 2nd quarter valued at approximately $34,000. Nisa Investment Advisors LLC lifted its stake in DocGo by 693.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company’s stock valued at $37,000 after acquiring an additional 10,565 shares during the period. SG Americas Securities LLC acquired a new stake in DocGo during the 2nd quarter valued at approximately $60,000. Finally, Victory Capital Management Inc. lifted its stake in DocGo by 124.0% during the 2nd quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock valued at $79,000 after acquiring an additional 14,191 shares during the period. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Price Performance

DCGO opened at $4.09 on Monday. DocGo Inc. has a 1 year low of $2.75 and a 1 year high of $6.20. The firm has a fifty day moving average price of $3.50 and a 200 day moving average price of $3.35. The stock has a market cap of $417.38 million, a P/E ratio of 14.61, a P/E/G ratio of 3.76 and a beta of 0.89.

Analyst Ratings Changes

DCGO has been the subject of several research reports. Cantor Fitzgerald restated an “overweight” rating and set a $5.00 price objective on shares of DocGo in a research note on Friday, September 20th. Needham & Company LLC reiterated a “buy” rating and issued a $7.00 target price on shares of DocGo in a research note on Thursday, August 8th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $6.10.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.